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CARBAPENEM-RESISTANT ACINETOBACTER BAUMANII POSTOPERATIVE MENINGITIS 
(ABSTRACT): Acinetobacter baumannii is an opportunistic pathogen of increasing relevance in hospital 
infections during the last 15 years.This organism causes a wide range of infection .Extensive use of 
antibiotics within hospitals has contribute to the emergence of multidrug-resistent A.baumannii strains 
that exhibit resistance to a wide range of antibiotics ,including carbapenems.We report the case of an 37 
years old man diagnosed with Acinetobacter multidrug-resistant post-neurosurgical meningitis with fatal 
outcome. 
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INTRODUCTION 
Acinetobacter baumannii is an opportunistic germ of clinical importance in 
continuous boost for the last 15 years, which can determine a big number of infections: 
sepsis, pneumonias, plague infections, urinary tract infections and post-operation 
meningitis, especially in the patients of the intensive care units [1].   
The emergence of resistance of Acinetobacter to a wide range of antibiotics 
makes these infections almost impossible to treat.  
 
CASE PRESENTATION 
We would like to present the case of a patient of 37 years old, hospitalized twice 
in our clinic through transfer from the Neurosurgery Hospital in February and April 
2005. This youngster was the victim of a labor accident in February 2005, which 
resulted into craniocerebral injury, right frontal and orbital sinus, for which it was 
preceded surgically.  
Postoperative, after 24 hours, the patient presents fever, the lumbar puncture 
showing pleiocitosis thus being transferred to the Clinic of Infectious Diseases, with the 
suspicion of bacterial meningitis. 
At his first hospitalization (in February 2005): patient was in vegetative status, 
tube fed. The lumbar puncture presents milky cephalorachidian liquid, with 1500 
elements/mmc, with PN prevalence. The fever occurrence immediately after the surgery 
indicates the suspicion of post-traumatic meningitis and not a nozocomial meningitis 
and it was initiated a treatment in association with 3
rd generation Cefalosporine and 
Ciprofloxacin. In his 8
th day of hospitalization the patient presents convulsions at the 
level of his right hemicorpus.  
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He is evaluated again in the Neurosurgical Clinic and a new surgical 
intervention is done to solve the cranionasal fistula and in order to evacuate a left 
parietal hematoma. The evolution is aggravated by incidence of a stercoral peritonitis 
through the rectum rupture for which it was surgically performed a temporary 
colostomy. During all this time he received treatment with 3
rd generation Cefalosporine, 
Fluoroquinolone and Metronidazol. The patient becomes feverish, the lumbar puncture 
presents milky cephalorachidian liquid (LCR), and the cerebral CT examination 
indicates: bilateral hemispheric diffuse edema, contrast clutch with aspect of epidural 
and epicranial biconvex lens at the level of the left frontal craniotomy area (aspect of 
meningo-encefalitis and non-surgical epiduritis at that specific moment). The patient 
returns to our clinic for further investigations and treatment. 
At the moment of the hospitalization the patient was in a serious general 
condition, with obstruction in the tracheo-bronchial area, requires oxygen and frequent 
aspiration of the tracheo-bronchial areas. The lumbar puncture presents milky purulent 
cephalorachidian liquid (LCR), with intense inflammatory reaction. At the direct 
examination there was observed Gram-negative diplococci and coco bacillus. Given the 
patient status, the multiple surgical interventions and the anterior prolonged treatment 
with antibiotics it was supposed the implications of several germs with multiple 
resistance to antibiotics and it was proceeded to the treatment with Vancomycin 1g/day 
and Meropeneme 3g/day  The cultures obtained from the cephalorachidian liquid were 
positive for Acinetobacter baumannii and the resistance profile of the stem had raised 
serious problems when choosing the accurate treatment. Acinetobacter baumannii 
provided resistance to ampicilline, amoxicilline-clavulanic acid , ticarcilline, 
ticarcilline- clavulanic acid , 3
rd generation cephalosporin ,quinolones, trimethoprim- 
sulfamethoxazole , aminoglycozides ,imipenem,meropenem, and cefoxitin. 
The thoracic radiography proves the aspect of bronchopneumonia (Table 1). The 
biological analysis emphasizes an important inflammatory syndrome and severe anemia 
(Table 2). 
 
Table 1 
Results of imagistic exploration 
IMAGISTIC EXPLORATION  RESULTS 
Thoracic radiography (11.04)  intense and homogenous opacity with retractile character, 
left hemithorax 
Abdominal ultrasonography  kidneys with extended sinus areas 
Cerebral CT  cerebral edema, contrast clutch at the right frontal level 
 
Table 2 
Biological probes 
  11.04 18.04 
Haematocrit 3.300.000  2.290.000. 
Hemoglobin 10  6,9 
Leucocytes 30.000.  17.300. 
Segmented neutrophils  90%  88% 
Eosinophils   1% 
Lymphocytes 5%  7% 
Monocyte 5%  4% 
Basophils    
Trombocytes 305.000.  246.000. 
Fibrinogen 408  mg%   
VSH 120  mm/1h   Cazuri clinice                                                          Jurnalul de Chirurgie, Iaşi, 2011, Vol. 7, Nr. 1 [ISSN 1584 – 9341] 
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In the light of the new information, the choice for an association of efficient 
antibiotics had proven to be impossible. It was chosen for the association of 
Vancomycin and Pefloxacine but the evolution was unfavorable and the pleiocytosis 
persisted in the cephalorachidian liquid (LCR) (Table 3). 
 
Table 3 
Examination of the cephalorachidian liquid 
11.04 Cephalorachidian  liquid aspect  Elements  Sediment 
  blur  uncountable  PN 95%, L 5% 
14.04  blur  uncountable  PN 90%, L 7% 
18.04  blur  uncountable  PN 71%, L 25% 
 
In the 8
th day of hospitalization the patient presents troubles of respiratory 
rhythm with desaturation, needing the transfer into the Neurosurgery Intensive Care 
Unit for ventilation support where he later deceases. 
 
DISCUSSIONS 
Acinetobacter baumannii is an opportunistic germ of clinical importance in 
continuous boost for the last 15 years, which can determine a big number of infections: 
sepsis, pneumonias, plague infections, urinary tract infections and post-operation 
meningitis, especially in the patients of the intensive care units [1]. The excessive 
utilization of the antibiotics in the hospitals had lead to an increase of A.baumannii 
stems with extended resistance to antibiotics, including to the new generations of 
extended-spectrum of Betalactamine, Aminoglycoside and Fluoroquinolone [2]. The 
Carbapenemes were, until recently, elective antibiotics for the treatment of the 
infections determined by the stems of A.baumannii multidrug–resistant. However 
Acinetobacter can develop a resistance to Carbapenemes through different mechanisms: 
decreasing the membrane permeability, supra expressing the efflux pumps and the 
Carbanemases production [3].  
During the last years the resistance to Carbapenemes was especially attributed to 
the production of D class Carbapenemases (Carbapenem-hydrolysing oxacillinases) 
OXA -24, OXA-24, OXA- 58 and the enzymes OXA -51like and less frequent to B 
class metallo-betalactamases of (MBLs) type IMP, VIP and SIM [3].  
Acinetobacter baumannii multidrug-resistant can trigger epidemics in the 
hospital departments [4,5] (as described in hospitals from Greece and Poland) where it 
can survive for longer periods of time. 
The Carbapenemes have constituted for a long time the only hope in the 
treatment of the infections with Acinetobacter multidrug resistant and continues to be, 
in many areas, still active. Evidences about the resistance to Carbapenemes were 
mentioned all over the world [6,7]. Recently, it has been proven the increase of the 
infection incidence with these stems in the hospitals from USA and Europe, after the 
return of the militaries from Iraq and in Romania as well [8]. According to a MART-T 
study accomplished in four university center (Iasi, Constanta, Timisoara and the 
Institute ,,Matei Bals” from Bucharest) during July 2008 – December 2009, it was 
noticed that the volume of Acinetobacter stems sensible to Carbapenemes has largely 
decreased as compared to the year 2007: p < 0,0001 being identified in approximately 
28% of the cases [9]. For these situations we have only a few therapeutic options and Cazuri clinice                                                          Jurnalul de Chirurgie, Iaşi, 2011, Vol. 7, Nr. 1 [ISSN 1584 – 9341] 
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the circumstances of central nervous system infections are more dramatic as the 
therapeutic arsenal is somehow reduced.  
The risk factors for the infections with Acinetobacter multidrug resistant to 
antibiotics are: prolonged hospitalization - especially in the intensive care units, 
invasive devices, immune depression and anterior treatment with antibiotics, including 
Carbapenemes. 
The patient presented in this case study was hospitalized post-operation in the 
intensive care unit (The Neurosurgical Hospital, the Clinic of Infectious Diseases) for a 
period of approximately 50 days. Prolonged hospitalization - especially in the intensive 
care units, during wich he received multiple antimicrobials, includig  3
rd generation 
Cefalosporine, Fluoroquinolone and carbapenems ,multiples invasive devices , result in 
high risk of infection with MDR – Acinetobacter.  During the first period episode of 
meningitis occurred within 24 hours after the operation, there was no suspicion for a 
nozocomial etiology of the infection (reason for which it was initiated the treatment 
with Ceftazidime and Ciprofloxacin, which are proven to cover the etiology of a post-
traumatic meningitis). During the second round of hospitalization, after several surgical 
interventions and hospitalizations in intensive care units, it was emphasized the possible 
implication of the Meticilline-resistant Staphylococcus Aureus of the resistant non-
fermentative Gram-negative bacillus. It was initiated the associated treatment with 
Vancomycin and Meropeneme.   
The cultures obtained from the cephalorachidian liquid (LCR) have isolated 
Acinetobacter baumannii with intermediate resistance to Ofloxacine and Pefloxacine 
and resistant to Cephalosporin, Ciprofloxacin and Carbapenemes.These strains of 
Acinetobacter could infect a patient ,,per primam,, or, become resistant because of 
antimicrobial pressure. The main characteristic of A. baumannii is the capability of 
surviving for prolonged periods in the environment, thus contributing to the 
transmission of the organism during outbreaks.  
The intestinal tract provides also, an important reservoir for antibiotic-resistant 
gram-negative bacilli,including Enetrobacteriacee species, Pseudomonas aeruginosa, 
and Acinetobacter baumannii.Selected pressure exerted by antibiotics play a crucial role 
in emergence and dissemination of these pathogens [10]. In this particular case, 
intestinal  colonization was possible during his prolonged hospitalization and 
antimicrobial treatments.The  incidence of a stercoral peritonitis through the rectum 
rupture resulted in translocation of MDR –Acinetobacter ,as a second possible source of 
infection. 
The antibiogram gives us no possibility to treat such an infection.                                  
The subsequent treatment  of meningitis with Vancomycin and Pefloxacine was 
inefficient. In the 8
th day of hospitalization the patient presents troubles of respiratory 
rhythm with desaturation and died. 
This case is an example of worse outcome in a serious ill patient when an 
antibiotic therapy is no more available. 
Colistin seems to be the break away solution of the moment, according to the 
studies proceeded in areas where there have been registered real epidemic infections 
with  Acinetobacter multidrug/pan drug resistant. The microbiological studies have 
compared the efficiency of Colistin in mono therapy vs. associations, identifying a 
synergic effect for Colistin - Rifampicin, Colistin – Carbapenemes [11]. The reduced 
permeability of the Colistin in the cephalorachidian liquid (LCR) represents the main 
disadvantage for treating the infections of the central nervous system (SNC). However, Cazuri clinice                                                          Jurnalul de Chirurgie, Iaşi, 2011, Vol. 7, Nr. 1 [ISSN 1584 – 9341] 
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there are studies according to which these patients could beneficiate of intrathecal or 
intraventricular administration of Colistin, with more than 80% success rate [12]. 
 
CONCLUSIONS 
Meningitis with resistant non-fermentative Gram-negative bacillus represents a 
permanent provocation due to treatment difficulties in the conditions of a reduced 
arsenal of antibiotics. The amount of Acinetobacter baumannii stems resistant to 
Carbapenemes reaches disturbing limits in Europe (Poland, Greece) but in Romania as 
well (where approximately 28% of the stems are sensible to Carbapenemes). The risk 
factors for the infections with Acinetobacter with multiple resistances to antibiotics are: 
prolonged hospitalization - especially in intensive care units, invasive devices, immune 
depression and anterior treatment with antibiotics, including Carbapenemes. The new 
options for all these infections are the synergic associations such as Colistin - 
Rifampicin, Colistin - Carbapenemes. 
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